{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T09:58:30Z","timestamp":1784282310591,"version":"3.55.0"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1097\/tp.0000000000001453","type":"journal-article","created":{"date-parts":[[2016,8,19]],"date-time":"2016-08-19T17:20:39Z","timestamp":1471627239000},"page":"1924-1934","source":"Crossref","is-referenced-by-count":48,"title":["Incidence of Posttransplantation Diabetes Mellitus in De Novo Kidney Transplant Recipients Receiving Prolonged-Release Tacrolimus-Based Immunosuppression With 2 Different Corticosteroid Minimization Strategies"],"prefix":"10.1097","volume":"101","author":[{"given":"Georges","family":"Mourad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Glyda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Albano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Viklick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Merville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Tyd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"L\u00f5hmus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten H. L.","family":"Christiaans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malcolm W.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasrullah","family":"Undre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gbenga","family":"Kazeem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk R. J.","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-35-20210211","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/TP.0b013e318293fcf8","article-title":"New-onset diabetes after transplantation (NODAT): an evaluation of definitions in clinical trials","volume":"96","author":"First","year":"2013","journal-title":"Transplantation"},{"key":"R2-35-20210211","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc11-1230","article-title":"New-onset diabetes after renal transplantation: risk assessment and management","volume":"35","author":"Ghisdal","year":"2012","journal-title":"Diabetes Care"},{"key":"R3-35-20210211","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1097\/00007890-200003150-00035","article-title":"Safety and efficacy of tacrolimus in combination with mycophenolate mofetil (MMF) in cadaveric renal transplant recipients. FK506\/MMF Dose-Ranging Kidney Transplant Study Group","volume":"69","author":"Miller","year":"2000","journal-title":"Transplantation"},{"key":"R4-35-20210211","doi-asserted-by":"crossref","first-page":"583","DOI":"10.2337\/diacare.25.3.583","article-title":"Posttransplantation diabetes: a systematic review of the literature","volume":"25","author":"Montori","year":"2002","journal-title":"Diabetes Care"},{"key":"R5-35-20210211","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/TP.0b013e3182584831","article-title":"Cardiovascular consequences of new-onset hyperglycemia after kidney transplantation","volume":"94","author":"Wauters","year":"2012","journal-title":"Transplantation"},{"key":"R6-35-20210211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1034\/j.1600-6143.2003.00010.x","article-title":"Diabetes mellitus after kidney transplantation in the United States","volume":"3","author":"Kasiske","year":"2003","journal-title":"Am J Transplant"},{"key":"R7-35-20210211","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1097\/01.tp.0000259617.21741.95","article-title":"Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients","volume":"83","author":"Burroughs","year":"2007","journal-title":"Transplantation"},{"key":"R8-35-20210211","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2147\/DMSO.S19027","article-title":"New onset diabetes after transplantation (NODAT): an overview","volume":"4","author":"Pham","year":"2011","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R9-35-20210211","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/01.TP.0000154915.20524.0A","article-title":"Corticosteroid-free immunosuppression with tacrolimus, mycophenolate mofetil, and daclizumab induction in renal transplantation","volume":"79","author":"Rostaing","year":"2005","journal-title":"Transplantation"},{"key":"R10-35-20210211","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/TP.0b013e318203c25f","article-title":"New-onset diabetes mellitus in kidney transplant recipients discharged on steroid-free immunosuppression","volume":"91","author":"Luan","year":"2011","journal-title":"Transplantation"},{"key":"R11-35-20210211","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/SLA.0b013e318187d1da","article-title":"A prospective, randomized, double-blind, placebo-controlled multicenter trial comparing early (7 day) corticosteroid cessation versus long-term, low-dose corticosteroid therapy","volume":"248","author":"Woodle","year":"2008","journal-title":"Ann Surg"},{"key":"R12-35-20210211","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1097\/01.tp.0000188300.26762.74","article-title":"Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus\/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study","volume":"80","author":"Vitko","year":"2005","journal-title":"Transplantation"},{"key":"R13-35-20210211","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/01.TP.0000140969.43761.1F","article-title":"Steroid withdrawal in renal transplant patients on triple therapy with a calcineurin inhibitor and mycophenolate mofetil: a meta-analysis of randomized, controlled trials","volume":"78","author":"Pascual","year":"2004","journal-title":"Transplantation"},{"key":"R14-35-20210211","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2215\/CJN.01800506","article-title":"Steroid sparing in kidney transplantation: changing paradigms, improving outcomes, and remaining questions","volume":"1","author":"Augustine","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R15-35-20210211","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/TP.0b013e3182a203bd","article-title":"OSAKA trial: a randomized, controlled trial comparing tacrolimus QD and BD in kidney transplantation","volume":"96","author":"Albano","year":"2013","journal-title":"Transplantation"},{"key":"R16-35-20210211","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/j.1600-6143.2007.01749.x","article-title":"Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus","volume":"7","author":"Vincenti","year":"2007","journal-title":"Am J Transplant"},{"key":"R17-35-20210211","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1681\/ASN.2007111202","article-title":"Sirolimus is associated with new-onset diabetes in kidney transplant recipients","volume":"19","author":"Johnston","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R18-35-20210211","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.trre.2013.06.001","article-title":"Review of combination therapy with mTOR inhibitors and tacrolimus minimization after transplantation","volume":"27","author":"Peddi","year":"2013","journal-title":"Transplant Rev (Orlando"},{"issue":"Suppl 1","key":"R19-35-20210211","first-page":"S11","article-title":"Standards of medical care in diabetes2010.","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"R20-35-20210211","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/j.1600-6143.2009.02834.x","article-title":"Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"9","author":"Kidney","year":"2009","journal-title":"Am J Transplant"},{"key":"R21-35-20210211","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R22-35-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/TP.0b013e3181c518cc","article-title":"Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis","volume":"89","author":"Knight","year":"2010","journal-title":"Transplantation"},{"key":"R23-35-20210211","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1111\/j.1600-6143.2010.03256.x","article-title":"Tacrolimus once daily (ADVAGRAF) versus twice daily (PROGRAF) in de novo renal transplantation: a randomized phase III study","volume":"10","author":"Kr\u00e4mer","year":"2010","journal-title":"Am J Transplant"},{"key":"R24-35-20210211","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1097\/00007890-201007272-01333","article-title":"Defining new-onset diabetes after transplantation (NODAT)","volume":"90","author":"Dhadda","year":"2010","journal-title":"Transplantation"},{"key":"R25-35-20210211","doi-asserted-by":"crossref","first-page":"vi13","DOI":"10.1093\/ndt\/gfh1064","article-title":"Post-transplant diabetes mellitus: the last 10 years with tacrolimus","volume":"19","author":"B\u00e4ckman","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R26-35-20210211","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/ctr.12015","article-title":"Is it safe to withdraw steroids within seven days of renal transplantation?","volume":"27","author":"Zhang","year":"2013","journal-title":"Clin Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000001453","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:25:48Z","timestamp":1620962748000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201708000-00035"}},"subtitle":["ADVANCE, A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000001453","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.730161501.793556278","asserted-by":"object"}]},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}